ScholarIQanswers from OpenAlex & ORCID
Fang Liu
ResearcherPublications, citations & collaboration network
Fang Liu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Fang Liu have?
ScholarIQindexed works
Fang Liu has 368 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fang Liu have?
ScholarIQcitation count
Fang Liu has 4,295 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Fang Liu?
ScholarIQh-index
Fang Liu has an h-index of 34 in OpenAlex.
What is the i10-index of Fang Liu?
ScholarIQi10-index
Fang Liu has an i10-index of 103 in OpenAlex.
What is the ORCID of Fang Liu?
ScholarIQorcid
The ORCID for Fang Liu is on the source record.
What is the OpenAlex record for Fang Liu?
ScholarIQopenalex
The OpenAlex for Fang Liu is on the source record.
What are the most-cited papers on Fang Liu?
ScholarIQmost cited works
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang, Ying-Qin Li, Shao-Bo Liang, Wei Jiang, Fang Liu, Wen-Xiu Ge, Ling‐Long Tang, Yan-Ping Mao, Qing-Mei He, Xiao-Jing Yang, Yuan Zhang, Xin Wen, Jiän Zhang, Yaqin Wang, Panpan Zhang, Ying Sun, Jing‐Ping Yun, Jing Zeng, Li Li, Lizhi Liu, Na Liu, Jun Ma
Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis
Fang Liu, Qi Li, Bao Liu, Jie Liu, Hua Zhang, Dehai Che, Jingyan Cao, Jing Shen, Jianxiong Geng, Yi Bi, LieGuang Ye, Bo Pan, Yan Yu
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for <i>F508del-CFTR</i>
Carlos Milla, Félix Ratjen, Gautham Marigowda, Fang Liu, David Waltz, Margaret Rosenfeld
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
Yufeng Jiang, Xingwu Ran, Lijing Jia, Chuan Yang, Penghua Wang, Jianhua Ma, Bing Chen, Yanmei Yu, Bo Feng, Lili Chen, Han Yin, Zhifeng Cheng, Zhaoli Yan, Yuzhi Yang, Fang Liu, Zhangrong Xu
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
John McNamara, Susanna A. McColley, Gautham Marigowda, Fang Liu, Simon Tian, Caroline A. Owen, David Stiles, Chonghua Li, David Waltz, Linda T. Wang, Gregory S. Sawicki